Granted Patent
B2
US 7,476,404 · App. 11/785,797 · Granted Jan 13, 2009
Composition for treatment of bone loss
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The composition set forth provides for the treatment of bone loss and osteoporosis. The formulation combines Vitamin D; Calcium Citrate Malate; Potassium Citrate; Magnesium; Boron and Vitamin K. Each component has an effect on its own combined with a synergistic effect with the other components.
Claims (13)
1. A composition for the treatment of bone loss and osteoporosis, comprising
Vitamin D
700 IU;
Calcium Citrate Malate
500 mg;
Potassium Citrate
500 mg;
Magnesium
400 mg;
Boron
3 mg; and
Vitamin K
300 mcg.
Assignments (3)
RELEASE OF SECURITY INTEREST
Recorded Aug 13, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION (AS SUCCESSOR BY MERGER TO WACHOVIA BANK, NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: VITACOST.COM INC.
Reel/Frame 033525/0029 →
EMPLOYMENT, NON-COMPETITION AND PROPRIETARY RIGHTS AGREEMENT
Recorded Apr 25, 2011
From: GORSEK, WAYNE
To: VITACOST.COM INC.
Reel/Frame 026178/0890 →
SECURITY AGREEMENT
Recorded Aug 24, 2007
From: VITACOST.COM INC.
To: WACHOVIA BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 019733/0790 →
Continuity (1)